Long-term safety of certolizumab pegol in rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, psoriasis and Crohn’s disease: a pooled analysis of 11 317 patients across clinical trials
Crossref DOI link: https://doi.org/10.1136/rmdopen-2019-000942
Published Online: 2019-05-31
Published Print: 2019-05
Update policy: https://doi.org/10.1136/crossmarkpolicy
Curtis, Jeffrey R
Mariette, Xavier
Gaujoux-Viala, Cécile
Blauvelt, Andrew
Kvien, Tore K
Sandborn, William J
Winthrop, Kevin
de Longueville, Marc
Huybrechts, Ivo
Bykerk, Vivian P
Funding for this research was provided by:
UCB Pharma
